Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
Danny Rischin(Peter MacCallum Cancer Centre), Liz Kenny(Palo Alto University), Richard Fisher(Princess Margaret Cancer Centre), Jolie Ringash(University Health Network), Brian O’Sullivan(University of Toronto), Andy Trotti, Jean Bourhis(University of Lausanne), Kally Yuen(Princess Margaret Cancer Centre), Jacques Bernier(Ospedale San Giovanni Bellinzona), Michael Henke(Fraunhofer Institute for Material Flow and Logistics), Lester J. Peters(Peter MacCallum Cancer Centre), J. Giralt(Vall d'Hebron Hospital Universitari)
Cited by 372
Related Papers
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
|Head & Neck|2005|1.8k
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
|The Lancet|2002|1.7k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
|New England Journal of Medicine|1997|1.6k
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|1990|1.4k